New biomarkers, including DNA, RNA, and protein biomarkers, such as AFP fraction L3, and conventional laboratory metrics for HCC diagnosis were reviewed by Wang et al. [23]; however, M2BP was not included in the review. Here, AFP is linked to hepatocellular carcinoma.